title: [Preclinical and clinical data of the synthetic Xa inhibitor fondaparinux (Arixtra(®))].
authors.affiliation: iwao.suzuki@gsk.com
authors.forename: Iwao
authors.initials: I
authors.lastname: Suzuki
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Ozeki
mesh_terms: D000208:Acute Disease; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D000077425:Fondaparinux; D006801:Humans; D007279:Injections, Subcutaneous; D011134:Polysaccharides / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D011655:Pulmonary Embolism / Q000188:drug therapy*; D020246:Venous Thrombosis / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D011134:Polysaccharides; D000077425:Fondaparinux